Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Long-Term Outcome of Adolescents and Young Adults with Chronic Primary Immune Thrombocytopenia (ITP)

Alexandra Schifferli, Gautier Le Gavrian, Nathalie Aladjidi, Guillaume Moulis, Bertrand Godeau, Thierry Leblanc, Marc Michel, Guy Leverger, Helder Fernandes, Thomas Kuehne

Blood (2022) 140 (Supplement 1): 5551–5552.

https://doi.org/10.1182/blood-2022-169194

Published: 2022

Journal Articles

Immunomodulation with Romiplostim in Young Adult Primary Immune Thrombocytopenia (ITP) As Second-Line Strategy (iROM-study)

Alexandra Schifferli, Axel Rüfer, Alicia Rovo, Nathan Cantoni, Andreas Holbro, Geneviève Favre, Heike Faeth, Renata Rosa Pereira, Anna Wieland, Jan Dirks, Falk Nimmerjahn, Thomas Kuehne

Blood (2021) 138 (Supplement 1): 3149.

https://doi.org/10.1182/blood-2021-146648

Published: 2021

Journal Articles

Adolescents and Young Adults with Immune Thrombocytopenia (ITP): A Project of the Carmen-France and Parc-ITP Registry

Alexandra Schifferli, Guillaume Moulis, Bertrand Godeau, Thierry Leblanc, Marc Michel, Nathalie Aladjidi, Guy Leverger, Mohsen Saleh Elalfy, John Grainger, Meera B. Chitlur, Andrea Heiri, Susanne Holzhauer, Thomas Kuehne

Blood (2021) 138 (Supplement 1): 2079.

https://doi.org/10.1182/blood-2021-148488

Published: 2021

Journal Articles

Analysis of Children with Secondary ITP an Observational Study of Children of the Parc-ITP Registry of the Intercontinental Cooperative ITP Study Group (ICIS)

Alexandra Schifferli, MD, Andrea Heiri, Paul A. Imbach, MD, Thomas Kuehne, MD

Blood (2018) 132 (Supplement 1): 1146.

https://doi.org/10.1182/blood-2018-99-111287

Published: 2018

Journal Articles

A Comparative Prospective Observational Study of Children and Adults with Immune Thrombocytopenia: 2-Year Follow-up

Thomas Kuehne, MD, Alexandra Schifferli, MD

Blood (2016) 128 (22): 3741.

https://doi.org/10.1182/blood.V128.22.3741.3741

Published: 2016

NARROW

Long-Term Outcome of Adolescents and Young Adults with Chronic Primary Immune Thrombocytopenia (ITP)

Immunomodulation with Romiplostim in Young Adult Primary Immune Thrombocytopenia (ITP) As Second-Line Strategy (iROM-study)

Adolescents and Young Adults with Immune Thrombocytopenia (ITP): A Project of the Carmen-France and Parc-ITP Registry

Analysis of Children with Secondary ITP an Observational Study of Children of the Parc-ITP Registry of the Intercontinental Cooperative ITP Study Group (ICIS)

A Comparative Prospective Observational Study of Children and Adults with Immune Thrombocytopenia: 2-Year Follow-up

Email alerts

ASH Publications

American Society of Hematology

Long-Term Outcome of Adolescents and Young Adults with Chronic Primary Immune Thrombocytopenia (ITP)

Immunomodulation with Romiplostim in Young Adult Primary Immune Thrombocytopenia (ITP) As Second-Line Strategy (iROM-study)

Adolescents and Young Adults with Immune Thrombocytopenia (ITP): A Project of the Carmen-France and Parc-ITP Registry

Analysis of Children with Secondary ITP an Observational Study of Children of the Parc-ITP Registry of the Intercontinental Cooperative ITP Study Group (ICIS)

A Comparative Prospective Observational Study of Children and Adults with Immune Thrombocytopenia: 2-Year Follow-up

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only